Because the promoter methylation of E2F1-dependent proapoptotic genes is a step in apoptotic defense mechanisms,12 the simultaneous inhibition of both SET9 and DNMT1 in the presence of DNA damage may be required to favor the tumor-suppressor function of E2F1. The gene discussed is E2F1; the disease is neoplasm.